EUVIMEDEUVIMED entdecken
Crossref

Discovery of Pyrazolo[1,5- a ]pyrimidine Derivative as a Novel and Selective ALKBH5 Inhibitor for the Treatment of AML

Ying-Zhe Wang, Hong-Yu Li, Yan Zhang, Rui-Xin Jiang, Jun Xu, Jing Gu, Zheng Jiang, Zheng-Yu Jiang iD, Qi-Dong You iD, Xiao-Ke Guo iD

Journal of Medicinal Chemistry · 2023

DOI: 10.1021/acs.jmedchem.3c01374 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Ying-Zhe Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, and Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 2100…. Hauptthemen laut MEDLINE: Dioxygenases, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Qinglan Project of Jiangsu Province of China, Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

M6A (N6-methyladenosine) plays a significant role in regulating RNA processing, splicing, nucleation, translation, and stability. AlkB homologue 5 (ALKBH5) is an Fe(II)/2-oxoglutarate (2-OG)-dependent dioxygenase that demethylates mono- or dimethylated adenosines. ALKBH5 can be regarded as an oncogenic factor for various human cancers. However, the discovery of potent and selective ALKBH5 inhibitors remains a challenge. We identified DDO-2728 as a novel and selective inhibitor of ALKBH5 by structure-based virtual screening and optimization. DDO-2728 was not a 2-oxoglutarate analogue and could selectively inhibit the demethylase activity of ALKBH5 over FTO. DDO-2728 increased the abundance of m6A modifications in AML cells, reduced the mRNA stability of TACC3, and inhibited cell cycle progression. Furthermore, DDO-2728 significantly suppressed tumor growth in the MV4-11 xenograft mouse model and showed a favorable safety profile. Collectively, our results highlight the development of a selective probe for ALKBH5 that will pave the way for the further study of ALKBH5 targeting therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DioxygenasesLeukemia, Myeloid, AcuteHumansMiceAnimalsKetoglutaric AcidsPyrimidinesAlkB Homolog 5, RNA DemethylaseMicrotubule-Associated ProteinsAlpha-Ketoglutarate-Dependent Dioxygenase FTO

Substanzen

Ketoglutaric AcidsDioxygenasesPyrimidinesAlkB Homolog 5, RNA DemethylaseTACC3 protein, humanMicrotubule-Associated ProteinsFTO protein, humanAlpha-Ketoglutarate-Dependent Dioxygenase FTOALKBH5 protein, human

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines, and Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China.
  • Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China.

ORCID-Profile: Zheng-Yu Jiang, Qi-Dong You, Xiao-Ke Guo

Förderung

  • Qinglan Project of Jiangsu Province of China
  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China

Zitieren

APA

Wang, Y. Z., Li, H. Y., Zhang, Y., Jiang, R. X., Xu, J., Gu, J., Jiang, Z., Jiang, Z. Y., You, Q. D., & Guo, X. K. (2023). Discovery of Pyrazolo[1,5- a ]pyrimidine Derivative as a Novel and Selective ALKBH5 Inhibitor for the Treatment of AML. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.3c01374

Vancouver

Wang YZ, Li HY, Zhang Y, Jiang RX, Xu J, Gu J, et al. Discovery of Pyrazolo[1,5- a ]pyrimidine Derivative as a Novel and Selective ALKBH5 Inhibitor for the Treatment of AML. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.3c01374

BibTeX
@article{Wang2023,
  author = {Wang, Ying-Zhe and Li, Hong-Yu and Zhang, Yan and Jiang, Rui-Xin and Xu, Jun and Gu, Jing and Jiang, Zheng and Jiang, Zheng-Yu and You, Qi-Dong and Guo, Xiao-Ke},
  title = {Discovery of Pyrazolo[1,5- a ]pyrimidine Derivative as a Novel and Selective ALKBH5 Inhibitor for the Treatment of AML},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  doi = {10.1021/acs.jmedchem.3c01374}
}
Kostenlos starten →